ThioMatrix is specialised on the development of non-invasive drug delivery systems utilizing its core technologies: the Thiomer Technology and SEDDS Technology. Due to the great potential of these technologies the efficacy of non-invasively delivered:
-therapeutic peptides
-peptidomimetics
-nucleic acids such as oligonucleotides, plasmid DNA and siRNA
-class III drugs according to the biopharmaceutical classification system (BCS)
-drugs being substrate of efflux pumps such as anticancer drugs
can be tremendously improved. A wide network of partnerships and collaborations with hospitals, veterinary institutions, CROs and universities has been established to conduct preclinical through to clinical development of our delivery products. This network coupled to our technologies and expertise gives us the edge to reduce the time to market to develop the optimal delivery systems for your therapeutic candidates. To learn more about our drug delivery technologies, please visit the technology section where you will also find the results of various in vivo studies demonstrating the advantages of our novel drug delivery products.
Company Details
- Employees
- 12
- Founded
- -
- Address
- Trientlgasse 65, Innsbruck,tyrol 6020,austria
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- http://thiomatrix.com
- Keywords
- Drug Delivery, Formulation Development, SEDDS, Pre-clinical studies, Oral peptide delivery, Thiomers.
- HQ
- Innsbruck, Tyrol
Thiomatrix Questions
Thiomatrix's website is http://thiomatrix.com
Thiomatrix's LinkedIn profile is https://at.linkedin.com/company/thiomatrix
Thiomatrix has
12 employees.
View email and phone details for 12
employees at Thiomatrix.
Thiomatrix's industry is
Research Services
Thiomatrix's categories are Research Services
Thiomatrix's founding year is 2003
